Professor Mibel Aguilar is a Bioanalytical and Biophysical Chemist at Monash University working across many disciplines and now specialising in research focuses on biomembrane nanotechnology and peptidomimetic drug design. She completed her PhD in Chemistry at the University of Melbourne studying the metabolism and toxicity of paracetamol. She then completed a Post Doctoral position at St Vincent’s Institute for Medical Research working on developing physical models for protein analysis and purification. She then moved to Monash University where her group now focuses on peptide-based drug design and biomembrane nanotechnology and are developing novel compounds that allow us to exploit the potential of peptides as drugs. She has published 164 papers and 24 book chapters, and edited a volume of Methods in Molecular Biology on HPLC publications. She has supervised several PhD and Honours students.